Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-23

FDA Approved: DALFAMPRIDINE — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma, Inc.'s original application for dalfampridine (generic). This marks the approval of a generic dalfampridine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (generic) (dalfampridine)

Snippet

ORIG AP for DALFAMPRIDINE (DALFAMPRIDINE)